Backed by $8.3M Financing, Synthego Launches With Synthetic Guide RNAs for CRISPR/Cas9 | GenomeWeb

This story has been edited to address guide RNA price comparisons between Synthego and certain competitors. An earlier version also included a quote comparing Synthego's prices to TriLink BioTechnologies'; however, TriLink offers Cas9 mRNA for CRISPR, not gRNA.

NEW YORK (GenomeWeb) – A new Silicon Valley-based biotech startup is hoping CRISPR/Cas9 genome editing is the perfect field to launch from.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.